Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

The Dialysis Patients Response to IV Iron with Elevated Ferritin (DRIVE) study demonstrated the efficacy of intravenous ferric gluconate to improve hemoglobin levels in anemic hemodialysis patients who were receiving adequate epoetin doses and who had ferritin levels between 500 and 1200 ng/ml and t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kapoian, Toros, O'Mara, Neeta B., Singh, Ajay K., Moran, John, Rizkala, Adel R., Geronemus, Robert, Kopelman, Robert C., Dahl, Naomi V., Coyne, Daniel W.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Nephrology 2008
נושאים:
Clinical Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2396742/
https://ncbi.nlm.nih.gov/pubmed/18216316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007050606
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים